Larson Financial Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334 Sell
13
-4
-24% -$93 ﹤0.01% 3557
2026
Q1
$350 Sell
17
-305
-95% -$6.88K ﹤0.01% 3381
2025
Q4
$7.63K Sell
322
-25
-7% -$609 ﹤0.01% 2268
2025
Q3
$8.64K Buy
347
+34
+11% +$732 ﹤0.01% 2095
2025
Q2
$7.2K Buy
313
+119
+61% +$2.75K ﹤0.01% 1954
2025
Q1
$4.36K Buy
194
+193
+19,300% +$4.48K ﹤0.01% 1921
2024
Q4
$20 Hold
1
﹤0.01% 2748
2024
Q3
$18 Hold
1
﹤0.01% 2676
2024
Q2
$17 Buy
+1
New +$18 ﹤0.01% 2410
2023
Q4
Sell
-51
Closed -$1.17K 1885
2023
Q3
$1.17K Buy
+51
New +$1.3K ﹤0.01% 1465

Other funds holding PRVA

Larson Financial Group's PRVA Position: Q2 2026 in Review

Larson Financial Group reduced its Privia Health (PRVA) stake by 24% in Q2 2026, selling an estimated $93 and leaving 13 shares worth $334. The position accounts for ﹤0.01% of the portfolio, ranked #3557.

Larson Financial Group first reported a position in PRVA in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.64K in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Larson Financial Group held 13 shares of Privia Health worth $334 as of Q2 2026.
  • Larson Financial Group sold 4 Privia Health shares in Q2 2026, an estimated $93.
  • Privia Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3557 holding.
  • Larson Financial Group first reported a position in Privia Health in Q3 2023 and has held it in 10 quarters since.
  • Larson Financial Group's Privia Health position peaked at $8.64K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.